Table 2 Summary of multivariate of Cox proportional regression for overall survival in 318 cases of NSCLC.

From: Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer

Parameter

B

SE

Wald

Sig.

Exp (B)

95.0% CI for Exp (B)

      

Lower

upper

Age

−0.153

0.199

0.593

0.441

0.858

0.580

1.268

Gender

−0.521

0.249

4.357

0.037*

0.594

0.364

0.969

Histological types

−0.040

0.215

0.034

0.853

0.961

0.630

1.465

LNM status

−0.976

0.252

15.020

0.000***

0.377

0.230

0.617

Clinical stages

−0.634

0.216

8.632

0.003***

0.530

0.347

0.810

Pathological grades

−0.486

0.202

5.801

0.016*

0.615

0.414

0.913

hsa-miR-7-5p

0.394

0.199

4.007

0.045*

1.491

1.008

2.204

MNK

−0.464

0.206

5.095

0.024*

0.629

0.420

0.941

  1. CI confidence interval, LNM lymph node metastasis, NSCLC non-small cell lung cancer.
  2. Note: multivariate analysis of Cox regression, *P < 0.05, ***P < 0.001.
Back to article page